Diabetic Macular Oedema
Intravitreal Bevacizumab in Diabetic Macular Oedema
... with diabetic macular oedema ...with diabetic macular ...had macular grid in conjunction with the intravitreal injection and the rest 57 eyes (54%) had PRP with the injection ...
6
<p>Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia</p>
... addition, diabetic eye disease, more speci- fi cally diabetic retinopathy (DR) and diabetic macular oedema (DMO), may cause debilitating visual impairment and is one of the most ...
9
The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema : an indirect comparison in a systematic review
... of diabetic macular ...in diabetic macular oedema, and therefore it is unlikely that ranibizumab would be cost effective compared with ...
17
<p>Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema</p>
... refractory diabetic macular oedema (DMO) in real life ...having macular oedema for another retinal disease were excluded from the ...
8
Cost effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
... DMO: Diabetic macular oedema; DRCR: Diabetic Retinopathy Clinical Research; DSA: Deterministic sensitivity analyses; ERG: Evidence Review Group; ETDRS: Early Treatment Diabetic ...
14
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
... Diabetic macular oedema (DMO) is a well- known and devastating complication of diabetes mellitus (DM) and is characterised by thickening of the macula due to accumu- lation of intraretinal and/or ...
6
Assessment of Severity Level for Diabetic Macular Oedema Using Machine Learning Algorithms
... The primary signs of the DME are neo-vascularization and abnormalities in blood vessels which were detected by using Fuzzy K-Means Clustering. This segmentation algorithm detects the presence and location of patholo- ...
8
Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
... Worldwide 422 million people have diabetes [1]. A third of these people have diabetic retinopathy (DR) and of these a further third have vision threatening DR includ- ing diabetic macular ...
7
Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
... Patients were properly positioned on a stable chair with the chin rested on the slit lamp that was mounted with a laser wavelength, Carl Zeiss Visulas 532S laser system. Patients were given grid or focal laser depending ...
6
Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
... Ocular pathologies involving macula are particularly destructive and irreversible to central visual acuity. Among myriad of various conditions, diabetic macular oedema (DME) is one of the leading ...
5
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema
... Aims To describe baseline characteristics and visual outcome for eyes treated with ranibizumab for diabetic macular oedema (DMO) from a multicentre database. Methods Structured clinical data were ...
7
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial
... Background: Intravitreal triamcinolone acetonide (IVTA) is an effective treatment for recalcitrant diabetic macular oedema (DMO). It has been shown to improve vision with benefits persisting up to ...
5
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
... Age-related macular degeneration; BGV: Bilateral good vision; BSE: Better-seeing eye; CINAHL: Cumulative Index of Nursing and Allied Health Literature; DMO: Diabetic macular oedema; DR: ...
13
Current treatments in diabetic macular oedema : systematic review and meta analysis
... central macular thickness; CSME, clinically significant macular oedema; DDS, dexamethasone; DIL, dexamethasone followed by laser; DM, diabetes mellitus; DMO, diabetic macular ...
60
Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
... Objective To investigate if the mean central retinal thickness (CRT) amplitude, measured between visits, is consistently decreased when switching from discontinuous to continuous therapy for diabetic ...
6
Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting
... severe oedema with mean CRT of over 600 ...prior macular laser and all eyes had prior intravitreal ...of oedema that could be used to select the most justifiable cases for fluocino- lone ...
5
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
... to macular laser for people with central retinal thickness ≥ 400 μ m (CRT), as determined by spectral domain optical coher- ence tomography (SD-OCT), and, thus, recommended these drugs for this group of ...
11
Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
... of oedema between FAc- treated and sham- treated eyes in quartile 1, indicating a possible correlation between improvements in DSS scores at year 3 and control of ...baseline oedema and lower vision, and ...
6
<p>Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study</p>
... Visual prognosis was guarded in patients with DME prior to the introduction of anti – vascular endothelial growth factor (anti – VEGF). 8 In DME, the superiority of an anti – VEGF agent (bevacizumab) over focal laser was ...
9
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema
... with diabetic retinopathy after cataract surgery is very variable, being primarily dependent on the level of diabetic ...National Diabetic Eye Screening ...
7